Production (Stage)
Hepion Pharmaceuticals, Inc.
HEPA
$0.0722
$0.009214.60%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.11M | -1.55M | -4.87M | -3.93M | -2.85M |
| Total Depreciation and Amortization | -- | 0.00 | 0.00 | 0.00 | 30.80K |
| Total Amortization of Deferred Charges | -- | 794.20K | 474.60K | -- | -- |
| Total Other Non-Cash Items | 4.82M | -444.00K | -38.30K | -4.50M | 1.34M |
| Change in Net Operating Assets | 167.20K | 44.30K | 1.91M | -2.50M | -2.14M |
| Cash from Operations | -1.12M | -1.15M | -2.52M | -10.93M | -3.62M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | -600.00K | -- | -- |
| Cash from Investing | -- | 0.00 | -600.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.90M | -- | -- | -- | -- |
| Issuance of Common Stock | 9.00M | 0.00 | 2.50M | 0.00 | 1.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -802.60K | -- | -- | -- | -- |
| Cash from Financing | 5.30M | 0.00 | 2.50M | 0.00 | 1.85M |
| Foreign Exchange rate Adjustments | -- | 62.20K | 0.00 | -61.80K | 86.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.18M | -1.09M | -617.90K | -10.99M | -1.68M |